A mechanically resilient soft hydrogel improves drug delivery for treating post-traumatic osteoarthritis in physically active joints
Proceedings of the National Academy of Sciences · 08.04.2025 · 122 (14)
DOI: 10.1073/pnas.2409729122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 31.03.2025. Verfasst von Nitin Joshi und 29 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanomedicine, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA 02115. Hauptthemen laut MEDLINE: Hydrogels, Osteoarthritis, Drug Delivery Systems. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Abdulaziz City for Science and Technology through the Center of Excellence for Biomedicine, Rheumatology Research Foundation (RRF), HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Abstract (Originalsprache)
Intra-articular delivery of disease-modifying osteoarthritis drugs (DMOADs) is likely to be most effective in the early stages of post-traumatic osteoarthritis (PTOA), when symptoms are minimal, and patients remain physically active. To ensure effective therapy, DMOAD delivery systems therefore must withstand repeated mechanical loading without altering the kinetics of drug release. While soft materials are typically preferred for DMOAD delivery, mechanical loading can compromise their structural integrity and disrupt controlled drug release. In this study, we present a mechanically resilient soft hydrogel that rapidly self-heals under conditions simulating human running while maintaining sustained release of the cathepsin-K inhibitor L-006235, used as a proof-of-concept DMOAD. This hydrogel demonstrated superior performance compared to a previously reported hydrogel designed for intra-articular drug delivery, which, in our study, neither recovered its structure nor maintained drug release under mechanical loading. When injected into mouse knee joints, the hydrogel provided consistent release kinetics of the encapsulated drug in both treadmill-running and nonrunning mice. In a mouse model of severe PTOA exacerbated by treadmill-running, the L-006235 hydrogel significantly reduced cartilage degeneration, whereas the free drug did not. Overall, our data underscore the hydrogel’s potential for treating PTOA in physically active patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Nanomedicine, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA 02115.
- Harvard Medical School, Boston, MA 02115.
- Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
- National Center for Biotechnology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology, Riyadh 11442, Saudi Arabia.
- King Abdulaziz City for Science and Technology Center of Excellence for Biomedicine, Joint Centers of Excellence Program, King Abdulaziz City for Science and Technology, Riyadh 11442, Saudi Arabia.
- Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115.
ORCID-Profile: Nitin Joshi, Jing Yan, Kai Slaughter, Yufeng Wang, Nutan Bhingaradiya, Sachin Bhagchandani, Haya A Alfassam, Rachel Wai Chun Chu, Nicholas E Sherman, James N Luo, Thomas Conway, Luis Botelho, Jeffrey M Karp
Förderung
- King Abdulaziz City for Science and Technology through the Center of Excellence for Biomedicine
- Rheumatology Research Foundation (RRF)
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Football League Players Association (NFLPA)
- U.S. Department of Defense (DOD)
- NIAMS NIH HHS
Zitieren
APA
Joshi, N., Yan, J., Dang, M., Slaughter, K., Wang, Y., Wu, D., Ung, T., Bhingaradiya, N., Pandya, V., Chen, M. X., Kaur, S., Bhagchandani, S., Alfassam, H. A., Joseph, J., Gao, J., Dewani, M., Chu, R. W. C., Yip, R. C. S., Weldon, E., …, & Ermann, J. (2025). A mechanically resilient soft hydrogel improves drug delivery for treating post-traumatic osteoarthritis in physically active joints. Proceedings of the National Academy of Sciences, 122(14). https://doi.org/10.1073/pnas.2409729122
Vancouver
Joshi N, Yan J, Dang M, Slaughter K, Wang Y, Wu D, et al. A mechanically resilient soft hydrogel improves drug delivery for treating post-traumatic osteoarthritis in physically active joints. Proceedings of the National Academy of Sciences. 2025;122(14). doi:10.1073/pnas.2409729122
BibTeX
@article{Joshi2025,
author = {Joshi, Nitin and Yan, Jing and Dang, Mickael and Slaughter, Kai and Wang, Yufeng and Wu, Dana and Ung, Trevor and Bhingaradiya, Nutan and Pandya, Virja and Chen, Mu Xian and Kaur, Shahdeep and Bhagchandani, Sachin and Alfassam, Haya A and Joseph, John and Gao, Jingjing and Dewani, Mahima and Chu, Rachel Wai Chun and Yip, Ryan Chak Sang and Weldon, Eli and Shah, Purna and Pisal, Nishkal Dhiraj and Shukla, Chetan and Sherman, Nicholas E and Luo, James N and Conway, Thomas and Eickhoff, James P and Botelho, Luis and Alhasan, Ali H and Karp, Jeffrey M and Ermann, Joerg},
title = {A mechanically resilient soft hydrogel improves drug delivery for treating post-traumatic osteoarthritis in physically active joints},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {14},
doi = {10.1073/pnas.2409729122}
}
EUVIMED